A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With COVID-related Pneumonia

MesenCure (adipose tissue derived activated mesenchymal stromal cells) - Wize Pharma, Bonus BioGroup

http://clinicaltrials.gov/ct2/show/NCT05497401

Aug 11, 2022